Medication Management and Neuropsychological Performance in Parkinson's Disease

Medication non-adherence is associated with chronic disease and complex medication schedules, and Parkinson's disease (PD) patients also frequently have cognitive impairments that may interfere with effective medication management. The current study quantitatively assessed the medication management skills of PD patients and probed the neurocognitive underpinnings and clinical correlates of this skill. A total of 26 men with PD completed a neuropsychological battery and a modified version of the Hopkins Medication Schedule (HMS), a standard test of a person's ability to understand and implement a routine prescription medication. Estimated adherence rates from performance on the HMS were low. Memory, executive functioning, and processing speed were strongly related to different components of the HMS. A range of neuropsychological abilities is associated with the ability to understand and implement a medication schedule and pillbox in individuals with PD.

[1]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[2]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[3]  Jeffery K. Allen,et al.  Prevalence and cost of medication nonadherence in Parkinson's disease: Evidence from administrative claims data , 2010, Movement disorders : official journal of the Movement Disorder Society.

[4]  J. Hanlon,et al.  Managing medications in clinically complex elders: "There's got to be a happy medium". , 2010, JAMA.

[5]  A. Lippman.  Adherence to medication. , 2005, The New England journal of medicine.

[6]  Ralph H. B. Benedict,et al.  Hopkins Verbal Learning Test--Revised , 2013 .

[7]  I. Bone,et al.  Suboptimal medication adherence in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[8]  Angelo Antonini,et al.  Adherence to antiparkinson medication in a multicenter European study , 2009, Movement disorders : official journal of the Movement Disorder Society.

[9]  J. Bainbridge,et al.  Challenges of Treatment Adherence in Older Patients with Parkinson’s Disease , 2009, Drugs & aging.

[10]  S. Doggrell,et al.  Adherence to Medicines in the Older-Aged with Chronic Conditions , 2010, Drugs & aging.

[11]  Qian-Li Xue,et al.  Validation of the Hopkins Medication Schedule to identify difficulties in taking medications. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[12]  Marcia Polansky,et al.  Drug adherence in Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[13]  J. Allaire,et al.  Everyday cognition: age and intellectual ability correlates. , 1999, Psychology and aging.

[14]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[15]  J. J. Ryan,et al.  Wechsler Adult Intelligence Scale-III , 2001 .

[16]  Daniel Weintraub,et al.  Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment. , 2008, The American journal of managed care.

[17]  H. Reichmann,et al.  Parkinson’s Disease and Related Disorders , 2006 .

[18]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[19]  J. Karlawish,et al.  Association between cognition and function in patients with Parkinson disease with and without dementia , 2010, Movement disorders : official journal of the Movement Disorder Society.

[20]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[21]  Daniel Weintraub,et al.  Impulse control disorders in Parkinson's disease: prevalence and possible risk factors. , 2009, Parkinsonism & related disorders.

[22]  Tiffany L. Young,et al.  Everyday reasoning abilities in persons with Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[23]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[24]  A. Siderowf,et al.  Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease , 2009, Neurology.

[25]  T. Goldberg,et al.  Performance-based measures of everyday function in mild cognitive impairment. , 2010, The American journal of psychiatry.

[26]  Angie A. Kehagia,et al.  Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease , 2010, The Lancet Neurology.